PUB - Publikationen an der Universität Bielefeld

Alle markieren

• [12]
  

  2021 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2946327

  M. Anselmi, et al., “Linker Hydrophilicity Modulates the Anticancer Activity of RGD-Cryptophycin Conjugates.”, Chemistry - A European Journal , vol. 27, 2021, pp. 1015-1022.

  PUB | PDF | DOI | WoS | PubMed | Europe PMC
   
• [11]
  

  2020 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2940382

  A.N. Borbély, et al., “Synthesis and Biological Characterization of Monomeric and Tetrameric RGD-Cryptophycin Conjugates.”, Chemistry - A European Journal, vol. 26, 2020, pp. 2602-2605.

  PUB | PDF | DOI | WoS | PubMed | Europe PMC
   
• [10]
  

  2019 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2936495

  A.N. Borbély, et al., “Conjugates of Cryptophycin and RGD or isoDGR Peptidomimetics for Targeted Drug Delivery”, ChemistryOpen, vol. 8, 2019, pp. 737-742.

  PUB | PDF | DOI | WoS | PubMed | Europe PMC
   
• [9]
  

  2019 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2934762

  A.N. Borbély, et al., “Synthesis and Biological Evaluation of RGD–Cryptophycin Conjugates for Targeted Drug Delivery”, Pharmaceutics, vol. 11, 2019, : 151.

  PUB | PDF | DOI | WoS | PubMed | Europe PMC
   
• [8]
  

  2019 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2935650

  E. Figueras Agustí, et al., “Octreotide Conjugates for Tumor Targeting and Imaging”, Pharmaceutics, vol. 11, 2019, : 220.

  PUB | PDF | DOI | WoS | PubMed | Europe PMC
   
• [7]
  

  2019 | Bielefelder E-Dissertation | PUB-ID: 2934464

  E. Figueras Agustí, Novel cryptophycin analogues and conjugates for tumor targeted therapy , Bielefeld: Universität Bielefeld, 2019.

  PUB | PDF | DOI
   
• [6]
  

  2018 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2920953

  E. Figueras Agustí, et al., “Novel unit B cryptophycin analogues as payloads for targeted therapy”, Beilstein Journal of Organic Chemistry, vol. 14, 2018, pp. 1281-1286.

  PUB | DOI | WoS | PubMed | Europe PMC
   
• [5]
  

  2018 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2932984

  S. Cazzamalli, et al., “In Vivo Antitumor Activity of a Novel Acetazolamide-Cryptophycin Conjugate for the Treatment of Renal Cell Carcinomas”, ACS Omega, vol. 3, 2018, pp. 14726-14731.

  PUB | PDF | DOI | WoS | PubMed | Europe PMC
   
• [4]
  

  2018 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2944897

  S. Cazzamalli, et al., “Correction: In Vivo Antitumor Activity of a Novel Acetazolamide–Cryptophycin Conjugate for the Treatment of Renal Cell Carcinoma”, ACS Omega, vol. 3, 2018, pp. 16743-16743.

  PUB | DOI | WoS | PubMed | Europe PMC
   
• [3]
  

  2018 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2931993

  A.N. Borbély, et al., “Novel Cryptophycin-based Conjugates for Tumor Targeting”, JOURNAL OF PEPTIDE SCIENCE, vol. 24, Hoboken: Wiley, 2018, pp.S59.

  PUB | WoS
   
• [2]
  

  2018 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2931996

  E. Figueras Agustí, et al., “Tumor Targeting of Cryptophycin based Conjugates Using Octreotide as Delivery Vehicle”, JOURNAL OF PEPTIDE SCIENCE, vol. 24, Hoboken: Wiley, 2018, pp.S166.

  PUB | WoS
   
• [1]
  

  2017 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2916981

  C. Weiss, et al., “Cryptophycins: cytotoxic cyclodepsipeptides with potential for tumor targeting”, Journal of Peptide Science, vol. 23, 2017, pp. 514-531.

  PUB | PDF | DOI | WoS | PubMed | Europe PMC